The pricing difference between compounded ($199-$399/mo) and branded options ($1,299-$1,399/mo) is substantial
Similarly, the development of thermosensitive gels, such as AC102, for intratympanic injection has shown safety and tolerability in human trials, demonstrating the feasibility of this approach for inner ear drug delivery (Lanting et al., 2025)
FDA-approved compounds have robust safety data
The patient did not report any side effects after the treatment
Efficacy and safety of oral semaglutide 14 mg (flexible dose) in early-stage symptomatic Alzheimers disease (evoke and evoke+): two phase 3, randomised, placebo-controlled trials
With informed guidance from healthcare professionals, alternative treatment plans can be tailored to each patient, potentially maintaining the quality of care during this shortage.